IGFBP-4 activates the Wnt/beta-catenin s
✍
Koji Ueno; Hiroshi Hirata; Shahana Majid; Z. Laura Tabatabai; Yuji Hinoda; Rajvi
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
French
⚖ 772 KB
## Abstract The Wnt/β‐catenin signaling pathway is inactivated by Wnt antagonists in most cancers and IGFBP‐4 is an antagonist of the Wnt/ β‐catenin signaling pathway. However, the function of IGFBP‐4 is not currently understood in renal cell carcinoma (RCC). We initially found that the expression